 VANCOUVER, Wash., March 16, 2022 GLOBE NEWSWIRE -- Absci Corporation Nasdaq: ABSI, a drug and target discovery company harnessing deep learning, AI and synthetic biology to expand the therapeutic potential of proteins, today announced that Absci Lead AI Scientist Joshua Meier will be presenting at NVIDIA GTC . 